Literature DB >> 19181530

Pharmacodynamics and pharmacokinetics studies of phenoxazinium derivatives for antimalarial agent.

Mei Yang1, Jian-Feng Ge, Chika Arai, Isamu Itoh, Qiang Fu, Masataka Ihara.   

Abstract

In vivo antimalarial drug candidates screening test was carried out on a series of water-soluble 3,7-bis(dialkylamino)phenoxazin-5-ium derivatives. Among them, 3-(diethylamino)-7-(piperidin-1-yl)phenoxazin-5-ium chloride (SSJ-206) showing highest efficacy was chosen for further pharmcodynamics and pharmacokinetics study. It was supported from these data that the phenoxazinium salts, SSJ-206, would be one of hopeful candidates as an oral antimalarial drug.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19181530     DOI: 10.1016/j.bmc.2009.01.021

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Discovery of Novel Benzo[a]phenoxazine SSJ-183 as a Drug Candidate for Malaria.

Authors:  Jian-Feng Ge; Chika Arai; Mei Yang; Abu Bakar Md; Jun Lu; Nasser S M Ismail; Sergio Wittlin; Marcel Kaiser; Reto Brun; Susan A Charman; Tien Nguyen; Julia Morizzi; Isamu Itoh; Masataka Ihara
Journal:  ACS Med Chem Lett       Date:  2010-07-12       Impact factor: 4.345

2.  In silico and in vivo anti-malarial investigation on 1-(heteroaryl)-2-((5-nitroheteroaryl)methylene) hydrazine derivatives.

Authors:  Azar Tahghighi; Seyed-Mahdi Mohamadi-Zarch; Hamzeh Rahimi; Mahya Marashiyan; Naseh Maleki-Ravasan; Ali Eslamifar
Journal:  Malar J       Date:  2020-06-29       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.